Advertisements



Gemphire Therapeutics Reports Fourth Quarter and Fiscal Year 2018 Financial Results

LIVONIA, Mich., March 15, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment of dyslipidemia, a serious.....»»

Category: earningsSource: benzingaMar 15th, 2019

Summit Therapeutics Reports Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2018 and Operational Progress

Conference Call Today at 1:00pm BST / 8:00am EDT OXFORD, United Kingdom and CAMBRIDGE, Mass.,.....»»

Category: earningsSource: benzingaApr 11th, 2018

AMSC Reports Fourth Quarter and Full Fiscal Year 2018 Financial Results and Provides Business Outlook

AMSC Reports Fourth Quarter and Full Fiscal Year 2018 Financial Results and Provides Business Outlook.....»»

Category: earningsSource: benzingaJun 5th, 2019

DeNA Reports Fourth Quarter and Fiscal Year 2018 Financial Results

TOKYO, May 10, 2019 (GLOBE NEWSWIRE) -- DeNA Co., Ltd. (TYO:2432) today announ.....»»

Category: earningsSource: benzingaMay 10th, 2019

francesca"s® Reports Fourth Quarter and Fiscal Year 2018 Financial Results

Fourth quarter net sales decreas.....»»

Category: earningsSource: benzingaMay 3rd, 2019

Emerald Health Therapeutics Reports Fourth Quarter and Fiscal 2018 Financial Results; Highlights Sales Growth in Q1 2019

VANCOUVER, British Co.....»»

Category: earningsSource: benzingaMay 1st, 2019

Eidos Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results

SAN FRANCISCO, April 15, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (NASDAQ:EIDX), today reported its financial results for the f.....»»

Category: earningsSource: benzingaApr 15th, 2019

Dais Announces Fourth Quarter and Fiscal 2018 Year-End Financial Results: Reports Continued Revenue Growth

ODESSA, FL, April 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Dais Corporation ("Dais" or .....»»

Category: dealsSource: nytApr 11th, 2019

Bed Bath & Beyond Inc. Reports Results For Fiscal 2018 Fourth Quarter And Full Year

UNION, N.J., April 10, 2019 /PRNewswire/ -- Bed Bath & Beyond Inc. (NASDAQ:BBBY) today reported financial r.....»»

Category: earningsSource: benzingaApr 10th, 2019

iAnthus Reports Fiscal Fourth Quarter and Full Year Unaudited 2018 Financial Results

Revenue generating in 9 of 11 states, and a footprint allowing for up to 63 dispensaries Fourth quarter revenue and other income of $.....»»

Category: earningsSource: benzingaApr 2nd, 2019

Energy Focus, Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results

SOLON, Ohio, April 01, 2019 (GLOBE NEWSWIRE) -- Energy Focus, Inc. (NASDAQ:EFOI), a leader in advanced LED lighting technologies, today announced financial results for its fourth quarter and fiscal year ended December 31, 2018......»»

Category: earningsSource: benzingaApr 1st, 2019

TCR2 Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

CAMBRIDGE, Mass., April 1, 2019 /PRNewswire/ -- TCR2 Therapeutics Inc. (NASDAQ:TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer, today reported financial re.....»»

Category: earningsSource: benzingaApr 1st, 2019

Converge Technology Solutions Reports Fourth Quarter and Fiscal Year 2018 Financial Results

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ .....»»

Category: earningsSource: benzingaMar 29th, 2019

Healthier Choices Management Corp. Reports Fourth Quarter 2018 Financial Results and Full Year Fiscal 2018 Results

Fourth Quarter Adjusted EBITDA Profit of $409k, Resulting in nearly a $1 million Improvement; Year-Over-Year Fourth Quarte.....»»

Category: earningsSource: benzingaMar 28th, 2019

Unum Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

- Advancing ATTCK-20-03 Phase 1 Trial in CD20+ Non-Hodgkin Lymphoma Toward Expansion Phase; Completing ATTCK-20-2 Study - - Continued.....»»

Category: earningsSource: benzingaMar 28th, 2019

Final Results

Summit Therapeutics plc(‘Summit', the ‘Company' or the ‘Group') Summit Therapeutics Reports Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2019 and Operational Pro.....»»

Category: earningsSource: benzingaMar 27th, 2019

Eyenovia Reports Fourth Quarter and Full Year 2018 Financial Results

NEW YORK, March 27, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-pri.....»»

Category: earningsSource: benzingaMar 27th, 2019

Iterum Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results

Iterum Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results.....»»

Category: earningsSource: benzingaMar 25th, 2019

MediWound Reports Fourth Quarter and Fiscal Year 2018 Financial Results

MediWound Reports Fourth Quarter and Fiscal Year 2018 Financial Results.....»»

Category: earningsSource: benzingaMar 25th, 2019

Destination XL Group, Inc. Reports Fiscal 2018 Fourth-Quarter and Full Year Financial Results

CANTON, Mass., March 22, 2019 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ:DXLG), the largest omni-channel spe.....»»

Category: earningsSource: benzingaMar 22nd, 2019

Glance Technologies Reports Financial Year 2018 Results

VANCOUVER, British Columbia, March 21, 2019 (GLOBE NEWSWIRE) -- Glance Technologies Inc. (CSE:GET, OTCQB:GLNNF) ("Glance" or the "Company") ​today announced financial results for the fourth quarter and fiscal year ended November 30, 20.....»»

Category: earningsSource: benzingaMar 21st, 2019